Corpay, Inc. CPAY
Verdict: Sell. Fair value $279 against a price of $332 on 12 Jan 2026, 16% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Key inputs for the Beneish M-Score calculation were unavailable (Current Assets, PPE, SG&A, Current.... Growth slows. Vulnerability to revenue shock (0.439 cushion).
Main risks
- Potential/actual debt covenant breach
- Thin revenue cushion: 0.4% decline causes EBIT loss
- High Leverage: A Debt/Equity ratio of 2.56 and Net Debt/EBITDA of 2.62x indicate a significant debt burden, increasing financial risk.
- Questionable Capital Allocation: The estimated 3-year ROIIC is very low at 6.1%, suggesting that incremental capital investments are generating poor returns, a red flag for the quality of future growth.
- Decelerating Growth & Volatile FCF: 1-year revenue growth of 5.6% is a sharp slowdown from the 3-year average of 11.9%. TTM FCF ($1.14B) has also declined significantly from prior annual levels ($1.77B-$1.95B).
- Market volatility